Authors
Loading...
Inhibition of irf5 reduces disease severity in mice with macrophage activation syndrome, indicating a potential treatment strategy.
Lu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: